Basiliximab allows for delayed calcineurin inhibitor initiation and preserves renal function without increasing acute rejection in liver transplant recipients.

被引：0
|
作者：
Taber, DJ [1 ]
Baillie, GM [1 ]
Lin, A [1 ]
Rogers, J [1 ]
Chavin, KD [1 ]
Baliga, PK [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1994
引用
收藏
页码：661A / 661A
页数：1
相关论文
共 50 条
  • [1] Basiliximab Induction and Delayed Calcineurin Inhibitor Initiation in Liver Transplant Recipients With Renal Insufficiency
    Verna, Elizabeth C.
    Farrand, Erica D.
    Elnaggar, Abdulrhman S.
    Pichardo, Elsa M.
    Balducci, Anastasia
    Emond, Jean C.
    Guarrera, James V.
    Brown, Robert S., Jr.
    [J]. TRANSPLANTATION, 2011, 91 (11) : 1254 - 1260
  • [2] Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction
    Lange, Nicholas W.
    Salerno, David M.
    Sammons, Chelsea M.
    Jesudian, Arun B.
    Verna, Elizabeth C.
    Brown, Robert S., Jr.
    [J]. CLINICAL TRANSPLANTATION, 2018, 32 (12)
  • [3] Delayed Calcineurin Inhibitor Introduction and Long Term Renal Outcomes in Liver Transplant Recipients Receiving Basiliximab Induction
    Lange, N.
    Salerno, D.
    Sammons, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 777 - 778
  • [4] Basiliximab (Simulect®) reduces the rate and severity of acute rejection in adult liver transplant recipients.
    Neuhaus, P
    Nashan, B
    Clavien, PA
    Kittur, D
    Salizzoni, M
    Rimola, A
    Abeywickrama, K
    Ortmann, CE
    Chodoff, L
    Hall, M
    Korn, A
    [J]. TRANSPLANTATION, 2000, 69 (08) : S118 - S118
  • [5] Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation
    Rosenberg, PB
    Vriesendorp, AE
    Drazner, MH
    Dries, DL
    Kaiser, PA
    Hynan, LS
    Dimaio, M
    Meyer, D
    Ring, WS
    Yancy, CW
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (09): : 1327 - 1331
  • [6] Calcineurin inhibitor-free imunosuppressive protocol with basiliximab induction and everolimus in de novo liver transplant recipients.
    Masetti, Michele
    Montalti, Roberto
    Rompianesi, Gianluca
    Di Benedetto, Fabrizio
    De Ruvo, Nicola
    Romano, Antonio
    Guerrini, Gian Piero
    Gerunda, Giorgio E.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S72 - S72
  • [7] Basiliximab Induction for Safe Delay of Calcineurin Inhibitors in High MELD Liver Transplant Recipients.
    Clark, J.
    Sparkes, T.
    Masters, B.
    LaMattina, J.
    Barth, R.
    Moss, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 560 - 560
  • [8] Delayed graft function with and without mycophenolate mofetil in cadaveric renal transplant recipients.
    Fabrizii, V
    Kaiser, A
    Mittermayer, C
    Muellner, M
    Woisetschlaeger, C
    Steiniger, R
    Muehlbacher, F
    Hoerl, WH
    Pohanka, E
    [J]. TRANSPLANTATION, 2000, 69 (08) : S329 - S329
  • [9] One Dose of Basiliximab in the Prevention of Acute Rejection in Renal Transplant Recipients
    Tian, Chuan
    Zhang, Xufeng
    Liu, Shuangde
    Yan, Jieke
    Wang, Hongwei
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (08): : 1553 - 1557
  • [10] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
12345